Marshall Wace North America’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-869,362
Closed -$21.7M 1737
2021
Q1
$21.7M Sell
869,362
-207,586
-19% -$5.49M 0.09% 241
2020
Q4
$29.6M Buy
+1,076,948
New +$28.9M 0.13% 183

Other funds holding SHC

Marshall Wace North America's SHC Position: Q2 2021 in Review

Marshall Wace North America sold out of Sotera Health (SHC) in Q2 2021, closing a stake of 869,362 shares — an estimated $21.7M sold.

Marshall Wace North America first reported a position in SHC in Q4 2020 and held it in 2 quarters. The position peaked at $29.6M in Q4 2020. 133 funds tracked by Wall St. Rank hold SHC as of Q2 2021.

  • Marshall Wace North America reported no remaining Sotera Health position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 869,362 Sotera Health shares in Q2 2021, an estimated $21.7M.
  • Marshall Wace North America first reported a position in Sotera Health in Q4 2020 and held it in 2 quarters.
  • Marshall Wace North America's Sotera Health position peaked at $29.6M in Q4 2020.
  • 133 funds tracked by Wall St. Rank held Sotera Health as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.